针对癌症的基因组维护缺陷,使用链终结核酸类型
Ryotaro Kawasumi1, Rubaiat E Tabassum1, Kouji Hirota1
1Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Tokyo, Japan.
Cancer science
|December 10, 2025
概括
新的化疗重新使用链终结核酸相似物 (CTNA) 来向癌症DNA修复缺陷. 这种精确的方法利用瘤的脆弱性,提高疗效和减少副作用,以改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的癌症疗法会导致DNA损伤,影响正常细胞并导致不良影响.
- 精密化疗利用瘤特异性的DNA修复缺陷,例如BRCA突变癌症的PARP抑制剂.
- 在DNA维护途径中的许多瘤突变在治疗上仍然未被准.
研究的目的:
- 建议重新利用链终结核酸相似物 (CTNA) 来针对由DNA维护缺陷引起的癌症脆弱性.
- 为了证明CTNA在具有特定DNA维护缺陷的细胞中引起合成致命性.
- 为CTNAs建立一个"修复缺陷指导"化疗框架.
主要方法:
- 研究CTNA对具有明显DNA维护缺陷的癌细胞的影响.
- 分析了CTNA诱导的DNA损伤和细胞修复途径.
- 在精准医学背景下评估CTNA的治疗潜力.
主要成果:
- 在缺乏特定DNA维护系统的细胞中,CTNA诱导合成致命性.
- CTNAs放大复制应激,导致癌细胞死亡.
- 识别了CTNA诱导的病变和细胞耐受性的必要修复途径.
结论:
- 可以将CTNA重新定位为由癌症特异性DNA修复缺陷引导的多功能化疗剂.
- 这种方法通过向更广泛的突变范围来扩大CTNA的临床实用性.
- 修复缺陷引导的CTNA疗法提供了改善的治疗效果,并可能减少副作用.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Nucleotide Excision Repair
4.9K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.9K
Nucleotide Excision Repair
40.5K
Overview
40.5K


